• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

MMA Payout

The Business of Combat Sports

  • Home
  • MMA
    • UFC
    • Bellator
    • One
    • PFL
  • Boxing
  • Legal
  • Ratings
  • Payouts
  • Attendance
  • Gate

Update on Povetkin-Wilder set for trial on Monday

February 1, 2017 by Jason Cruz 1 Comment

While the Al Haymon-Golden Boy lawsuit appears to be over barring an appeal, there is another boxing lawsuit set for trial next week. Deontay Wilder and Alexander Povetkin are set to go to trial this Monday.

A brief background can be found here.

The parties in the case have insisted that the lawsuit proceed to trial without need for unnecessary motions.  The deadline for discovery was December 15, 2016 with the attorneys for each side agreeing to a February 6, 2017 trial date.  Of course, that deadline has gone by the wayside as there have been depositions taking place as late as last week.

Lawyers for Povetkin and his promoter, World of Boxing, sought a continuance on the basis that there are now issues related to discovery that have yet to be resolved.

Countering that argument, Wilder’s attorneys state that the trial will be easy as there will only one question posed to the jury: whether Povetkin ingested Meldonium prior to its WADA ban on January 1, 2016.

But, as with most things, best-laid plans for a smooth trial are going out the door as the parties are squabbling over discovery in a case that the parties admitted would be straightforward.

Both sides are geared for trial and unless the parties can decide on a settlement of the funds which remain in escrow, it seems unlikely to happen.

As one might expect, the attorneys for each side are arguing over experts.

In the current battle, the attorneys for the World of Boxing are seeking to call back for a second deposition of Deontay Wilder’s expert, Anthony Butch, Ph.D.  World of Boxing claims that in the first deposition, Wilder’s expert did not provide certain information obtained from the Meldonium data he examined.  Wilder’s attorney argue that the information requested was a new request and outside the scope of the original subpoena for documents that was served for the deposition.

On the other end, Wilder’s attorneys have filed a Motion in Limine to exclude certain evidence it anticipates that the World of Boxing will used at trial.  Notably, it believes that World of Boxing will introduce evidence of two rulings of the World Boxing Council regarding Povetkin’s positive test.

The August 17, 2016 ruling asserts:

The October 7, 2016 ruling states:

Wilder’s attorneys argue that the information reflects only that the WBC denied rendering conclusions about when Povetkin ingested Meldonium.

It also wants to exclude evidence regarding the history of Meldonium as the issue is why Povetkin took Meldonium is the threshold issue at trial.  Rather, Wilder’s attorneys argue that the issue is whether Povetkink took Meldonium.  In addition, they want to exclude evidence regarding the amount of Meldonium detected would have a therapeutic or performance-enhancing effect. Also, the evidence regarding WADA’s June 30 Notice of Easing its “Zero Tolerance” Policy on Meldonium.

The judge has yet to rule on the issue but one might expect this to be cleared up at the February 3rd pretrial conference.

Clearly, World of Boxing would like the introduction of the information into evidence to put on the theme of its case of the reasons why Povetkin took Meldonium, that WADA retreated from its original ban of the drug andit was inconsequential to Wilder failing to show up at Russia to fight.

MMA Payout will keep you posted.

Filed Under: boxing, Featured, legal

Reader Interactions

Comments

  1. Wil says

    February 2, 2017 at 7:48 pm

    I hope Povetkin never fights again, I hope they ban him, he pissed hot for the Stiverne fight and then beat Duhapaus so badly it might have ended his career. This man is going to kill someone with his doping. Povetkin needs to be banned from boxing for life.

    Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

Featured

Court denies Top Rank’s Motion to Dismiss in Keane case

Opetaia fires back at IBF in opposition to MTD

UFC 331 Payout Perspective

UFC 331 attendance, gate and bonuses

Scott Coker is back with Ki MMA

TKO owns this weekend

Archives

MMA Payout Follow

MMAPayout
Retweet on Twitter MMA Payout Retweeted

UFC made $1.5 billion in revenue last year. $1 million for brain research through 2030. And they don’t provide long-term health insurance for retired fighters. Fighters carry the damage for life. UFC needs to do a lot more. This deserves scrutiny, not applause.

Retweet on Twitter MMA Payout Retweeted

🚨 BREAKING: A MVSU men's basketball player has been detained by ICE

Power forward Qingfang Pang is a junior originally from China, listed as having a US hometown in Flushing, Queens

He just transferred in from Monroe U. in NY

@ThaoTaTV is first on the story for @WJTV @WHLT22

This is why Dana likes podcasts that actual adversarial press conferences

Dana comparing #UFC to the Lakers to come up with his valuation of the brand

MMA Payout @MMAPayout

Dana White eyes $10B for UFC’s next rights deal https://www.sportsbusinessjournal.com/Articles/2026/10/08/dana-white-eyes-10b-for-ufcs-next-rights-deal/

Copyright © 2026 · MMA Payout: The Business of Combat Sports